TPP-26916-03768
2 vaccinations
3 coded responses
23 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 05-11
- ZIP prefix
- 940 / CA
- Registered
- 2021-11-24
- Relationship
- Child or adolescent in my care
- Guardian
- ZGX-23753-25300
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-24
Registered in v-safe
-
2021-11-24
Dose 1 — Pfizer-BioNTech
- 2021-11-24
- 2021-11-26
- 2021-11-27
- 2021-11-28
- 2021-11-29
-
2021-11-30
Survey response — days 1–6 daily, dose 1, dependentMedDRA: Nasal congestion — Feeling: GoodFree text: Stuffy noseMedDRA releases: 2024-11 · check-in free text available
- 2021-12-01
- 2021-12-10
- 2021-12-15
-
2021-12-18
Dose 2 — Pfizer-BioNTech
-
2021-12-20
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Site: Pain · NoneAdult check-in
- 2021-12-21
- 2021-12-22
- 2021-12-23
- 2021-12-24
- 2021-12-25
- 2022-01-01
- 2022-01-08
- 2022-01-15
- 2022-01-22
- 2022-01-29
-
2022-03-20
Survey response — 3 months, dose 2, dependentMedDRA: Nasopharyngitis, SARS-CoV-2 test negative — Feeling: FairFree text: Cold-like symptoms. Home COVID test was NEGATIVE.MedDRA releases: 2024-11 · check-in free text available
- 2022-06-18
-
2022-12-18
Survey response — 12 months, dose 2, dependentMedDRA: Respiratory disorder, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend schoolFree text: Upper respiratory illness x2 but tested negative for COVID both instances. Has also received her flu vax. Recovered within a few days with rest.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-24 | Pfizer-BioNTech | No |
| 2 | 2021-12-18 | Pfizer-BioNTech | No |
Free text
Release 10 — days 1–6 daily, dose 1, dependent
Systemic reaction (other): Stuffy nose
Release 11 — 3 months, dose 2, dependent
Symptoms: Cold-like symptoms. Home COVID test was NEGATIVE.
Release 12 — 12 months, dose 2, dependent
Symptoms: Upper respiratory illness x2 but tested negative for COVID both instances. Has also received her flu vax. Recovered within a few days with rest.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Respiratory disorder | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SRO | Nasal congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release